 "Sohini Das")
Sohini Das
Sohini Das
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Page 45 - Sohini Das
Audi to Merc, German carmakers drive luxury vehicle sales into high gear
2023 likely to be a record year for luxury car sales
 "Audi to Merc, German carmakers drive luxury vehicle sales into high gear")
The family and the feud: Trouble brews in the Raunaq Singh family
Sachit Kanwar moves court against father Surinder over settlement
 "The family and the feud: Trouble brews in the Raunaq Singh family")
IMA opposes NMC move to mandate doctors to prescribe only generic medicines
IMA felt that if the Centre is serious about implementing generic drugs, then it should not give licences to branded drugs at all, and at the same time ensure the quality of generic drugs
 "IMA opposes NMC move to mandate doctors to prescribe only generic medicines")
Pharma industry in a huddle after fresh NMC regulations for doctors
"Power thus shifts to chemists instead of doctors. Whichever company offers better incentives, the chemist would prefer it," the industry feared
 "Pharma industry in a huddle after fresh NMC regulations for doctors")
Medical Council guidelines bar doctors from taking freebies from firms
Industry insiders feel this is a step towards implementing and codifying the Uniform Code of Pharmaceutical Marketing Practices
 "Medical Council guidelines bar doctors from taking freebies from firms")
Health ministry proposes separate post for medical devices controller
Specific provision for recall of drugs and devices; penal provisions for substandard drugs
 "Health ministry proposes separate post for medical devices controller")
Biocon Biologics set to integrate Viatris' biosimilars biz ahead of plan
BBL is actively working on raising funds from private equity investors to retire part of the $1.4 billion debt that was incurred due to the acquisition
 "Biocon Biologics set to integrate Viatris' biosimilars biz ahead of plan")
Domestic PV wholesales rise 2.6% in July; two-wheelers down 7.2%: Siam
UV production experienced a 28.5 per cent growth in July, indicating a gradual resolution of the semiconductor crisis and improvements in the supply chain
 "Domestic PV wholesales rise 2.6% in July; two-wheelers down 7.2%: Siam")
Parliamentary committee recommends a separate medical devices Bill
According to sources, DCGI has convened a meeting in Delhi on August 10 to discuss matters related to the draft New Drugs, Medical Devices and Cosmetics Bill, 2023
 "Parliamentary committee recommends a separate medical devices Bill")
Fierce competition among new drug brands for share of India market
The competitive intensity is high between brands, at a time when volume growth in the domestic pharma market is on a slow lane
 "Fierce competition among new drug brands for share of India market")
Metropolis Healthcare eyes 60% revenue from B2C business in next 2-3 years
The diagnostic player has also taken price hikes in the range of 4-5 percent in the last three years
 "Metropolis Healthcare eyes 60% revenue from B2C business in next 2-3 years")
Won't invest in RBL further unless it sees 'compelling value': M&M
M&M Board had approved a stake buy of up to 4.5 per cent in RBL Bank
 "Won't invest in RBL further unless it sees 'compelling value': M&M")
M&M Q1 PAT up 60% to Rs 3,508 cr on strong auto performance, revenue up 19%
The board has recommended a dividend of Rs 16.25 per share
 "M&M Q1 PAT up 60% to Rs 3,508 cr on strong auto performance, revenue up 19%")
Industry, patient groups want draft drugs and medical devices Bill recalled
Seek a separate 'Medical Devices Act' distinct from the drug regulations Bill
 "Industry, patient groups want draft drugs and medical devices Bill recalled")
Sun Pharma Q1 PAT dips 2% on one-time expense; US revenues up 12%
Sun Pharma's stock ended flat at Rs 1140.85 on the BSE
 "Sun Pharma Q1 PAT dips 2% on one-time expense; US revenues up 12%")
Temasek Holdings funding drives M&M EV arm valuation to Rs 80,000 crore
Singapore investment firm to hold 1.49-2.97% stake in EV business
 "Temasek Holdings funding drives M&M EV arm valuation to Rs 80,000 crore")
Mankind Pharma PAT up 66% in Q1 to Rs 494 crore on revenue growth
Juneja also highlighted a 43 per cent YoY increase in Ebitda as a positive outcome of the company's previous initiatives to improve profitability
 "Mankind Pharma PAT up 66% in Q1 to Rs 494 crore on revenue growth")
Proxy advisors, analysts favour cash deal to acquire Suzuki Gujarat plant
Maruti says it wants to have multiple powertrain production at multiple locations under single control
 "Proxy advisors, analysts favour cash deal to acquire Suzuki Gujarat plant")
Maruti to acquire Suzuki Motor Corp's Gujarat plant to boost efficiency
Maruti will take over EV production at Gujarat site, replacing Suzuki Motor Corp
Allegra, Dolo-650 among 300 pharmaceutical brands to have QR codes
Batches manufactured on and after August 1 will have QR codes printed on the packaging of the selected 300 brands
 "Allegra, Dolo-650 among 300 pharmaceutical brands to have QR codes")